GR3031509T3 - Keratinocyte growth factor (KGF) for its use in method of therapeutic treatment for the human or animal body. - Google Patents

Keratinocyte growth factor (KGF) for its use in method of therapeutic treatment for the human or animal body.

Info

Publication number
GR3031509T3
GR3031509T3 GR990402604T GR990402604T GR3031509T3 GR 3031509 T3 GR3031509 T3 GR 3031509T3 GR 990402604 T GR990402604 T GR 990402604T GR 990402604 T GR990402604 T GR 990402604T GR 3031509 T3 GR3031509 T3 GR 3031509T3
Authority
GR
Greece
Prior art keywords
kgf
human
growth factor
therapeutic treatment
animal body
Prior art date
Application number
GR990402604T
Other languages
English (en)
Inventor
Glenn F Pierce
Regina M Housley
Charles F Morris
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21912689&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR3031509(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of GR3031509T3 publication Critical patent/GR3031509T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
GR990402604T 1993-03-26 1999-10-13 Keratinocyte growth factor (KGF) for its use in method of therapeutic treatment for the human or animal body. GR3031509T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4074293A 1993-03-26 1993-03-26

Publications (1)

Publication Number Publication Date
GR3031509T3 true GR3031509T3 (en) 2000-01-31

Family

ID=21912689

Family Applications (1)

Application Number Title Priority Date Filing Date
GR990402604T GR3031509T3 (en) 1993-03-26 1999-10-13 Keratinocyte growth factor (KGF) for its use in method of therapeutic treatment for the human or animal body.

Country Status (23)

Country Link
EP (1) EP0619370B1 (el)
JP (1) JP3578761B2 (el)
KR (1) KR100390340B1 (el)
CN (1) CN1064710C (el)
AT (1) ATE183233T1 (el)
AU (1) AU707340B2 (el)
CA (1) CA2159109C (el)
CZ (1) CZ285996B6 (el)
DE (1) DE69419958T2 (el)
DK (1) DK0619370T3 (el)
ES (1) ES2136673T3 (el)
FI (1) FI954541A (el)
GR (1) GR3031509T3 (el)
HU (1) HU220641B1 (el)
IL (4) IL109122A (el)
NO (1) NO953781L (el)
NZ (1) NZ263967A (el)
RU (1) RU2146148C1 (el)
SG (1) SG49841A1 (el)
SI (1) SI0619370T1 (el)
SK (1) SK281674B6 (el)
UA (1) UA46706C2 (el)
WO (1) WO1994023032A1 (el)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN271295A0 (en) * 1995-05-02 1995-05-25 Gropep Pty Ltd Method of treatment
EE03975B1 (et) * 1994-10-13 2003-02-17 Amgen Inc. Keratinotsüüdi kasvufaktori analoogid
AU708868B2 (en) * 1995-02-14 1999-08-12 Human Genome Sciences, Inc. Keratinocyte growth factor-2
US6693077B1 (en) 1995-02-14 2004-02-17 Human Genome Sciences, Inc. Keratinocyte growth factor-2
US6077692A (en) 1995-02-14 2000-06-20 Human Genome Sciences, Inc. Keratinocyte growth factor-2
US7232667B2 (en) 1995-02-14 2007-06-19 Human Genome Sciences, Inc. Keratinocyte growth factor-2 polynucleotides
JPH11513405A (ja) * 1995-10-11 1999-11-16 カイロン コーポレイション 創傷治癒のためのｐｄｇｆ、ｋｇｆ、ｉｇｆ、およびｉｇｆｂｐの配合物
GB9619660D0 (en) * 1996-09-20 1996-11-06 Scient Hospital Suppl Int Ltd Prevention of gastrointestinal damage
SI0941110T1 (en) * 1996-10-15 2004-06-30 Amgen Inc. Uses of keratinocyte growth factor-2
US6743422B1 (en) 1996-10-15 2004-06-01 Amgen, Inc. Keratinocyte growth factor-2 products
PT941110E (pt) * 1996-10-15 2004-07-30 Amgen Inc Utilizacao do factor 2 de crescimento dos ceratinocitos
US20010006939A1 (en) * 1997-10-03 2001-07-05 Ralph W. Niven Secretory leukocyte protease inhibitor dry powder pharmaceutical compositions
US6228839B1 (en) * 1997-12-19 2001-05-08 Emory University Use of keratinocyte growth factor to improve oxidative status
US6869927B1 (en) 1997-12-22 2005-03-22 Human Genome Sciences, Inc. Keratinocyte growth factor-2 formulations
NZ505324A (en) 1997-12-22 2002-11-26 Human Genome Sciences Inc Liquid and lyophilised KGF-2 polypeptide formulations used to accelerate soft tissue growth or regeneration
EP1054900A4 (en) 1998-02-13 2004-12-22 Human Genome Sciences Inc THERAPEUTIC USE OF THE KERATINOCTENT GROWTH FACTOR-2
US6335317B1 (en) 1998-04-10 2002-01-01 Emory University Use of gut-trophic growth factors to improve oxidative status
AU2001243657A1 (en) 2000-03-20 2001-10-03 Osi Pharmaceuticals, Inc Combined treatment with keratinocyte growth factor and epidermal growth factor inhibitor
CA2437270A1 (en) * 2001-02-06 2002-08-15 Merck Patent Gesellschaft Mit Beschraenkter Haftung Modified keratinocyte growth factor (kgf) with reduced immunogenicity
US7202066B2 (en) 2002-01-29 2007-04-10 Carrington Laboratories, Inc. Combination of a growth factor and a protease enzyme
EP1789138A2 (en) * 2004-09-13 2007-05-30 University Of Southampton Growth factor treatment for asthma
CN101822821B (zh) * 2010-04-27 2013-01-23 复旦大学附属中山医院 角质细胞生长因子-2在制备防治肺损伤的药物中的应用
CN104707164B (zh) * 2015-03-31 2017-01-18 中国人民解放军军事医学科学院基础医学研究所 一种复合壳聚糖水凝胶敷料及其制备方法和应用
CN106226511B (zh) * 2016-07-28 2018-04-06 苏州金盟生物技术有限公司 一种重组人角质细胞生长因子生物学活性检测方法
CN107753932A (zh) * 2016-08-22 2018-03-06 中国辐射防护研究院 Kgf在制备治疗或预防放射性肠炎药物中的用途
EP3888625A4 (en) 2018-11-27 2022-10-05 Jellyfish Research Laboratories, Inc. COMPOSITION FOR SCALP AND HAIR
KR20210114646A (ko) * 2020-03-11 2021-09-24 (주)메디코스바이오텍 성장인자를 함유하는 탈모 치료 또는 모발 성장 촉진용 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GEP20022681B (en) * 1989-01-31 2002-04-25 Aaronson Us Stuart A Protein KFG, Antibodies, Pharmaceutical Composition, Their Use, recombinant DNA, Cell, Method for Discoveries and Production of Proteins, Method for Stimulation of Epithelial Cells Growth
JPH04224522A (ja) * 1990-04-27 1992-08-13 Merck & Co Inc 繊維芽細胞増殖因子含有組成物による禿頭症の治療又は予防方法
AU1462392A (en) * 1991-02-22 1992-09-15 Amgen, Inc. Use of gm-csf and g-csf to promote accelerated wound healing

Also Published As

Publication number Publication date
ES2136673T3 (es) 1999-12-01
IL109122A0 (en) 1994-06-24
IL137581A (en) 2009-09-01
EP0619370A1 (en) 1994-10-12
DE69419958T2 (de) 2000-04-20
ATE183233T1 (de) 1999-08-15
CN1064710C (zh) 2001-04-18
KR960701204A (ko) 1996-02-24
IL109122A (en) 2004-07-25
NO953781L (no) 1995-11-27
DE69419958D1 (de) 1999-09-16
DK0619370T3 (da) 2000-02-28
JP2002526026A (ja) 2002-08-13
FI954541A0 (fi) 1995-09-25
CN1217022A (zh) 1999-05-19
NZ263967A (en) 2005-02-25
IL161568A0 (en) 2004-09-27
FI954541A (fi) 1995-11-23
IL137581A0 (en) 2001-07-24
SK281674B6 (sk) 2001-06-11
WO1994023032A1 (en) 1994-10-13
NO953781D0 (no) 1995-09-25
SG49841A1 (en) 1998-06-15
AU6524394A (en) 1994-10-24
CA2159109C (en) 2004-11-16
HU9502800D0 (en) 1995-12-28
CZ248295A3 (en) 1996-12-11
JP3578761B2 (ja) 2004-10-20
HU220641B1 (hu) 2002-03-28
RU2146148C1 (ru) 2000-03-10
KR100390340B1 (ko) 2003-09-26
AU707340B2 (en) 1999-07-08
CZ285996B6 (cs) 1999-12-15
HUT72711A (en) 1996-05-28
SK118595A3 (en) 1996-11-06
EP0619370B1 (en) 1999-08-11
SI0619370T1 (en) 1999-10-31
UA46706C2 (uk) 2002-06-17
CA2159109A1 (en) 1994-10-13

Similar Documents

Publication Publication Date Title
GR3031509T3 (en) Keratinocyte growth factor (KGF) for its use in method of therapeutic treatment for the human or animal body.
IL133253A0 (en) Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them
AU6721998A (en) Therapeutic use of the smr1 protein and active derivatives thereof
FR2644066B1 (fr) Compositions stabilisees comprenant des fgfs, leur procede d'obtention et leurs applications therapeutiques, chirurgicales et cosmetologiques
CA2218333A1 (en) Surgical method for rejuvenating or reshaping body members by bone grafting _______________________________________________________
AT398373B (de) Biologisches resorbierbares implantationsmaterial sowie verfahren zur herstellung desselben
DE69738336D1 (de) Verwendung von keratinocyte growth factor-2
AU4492393A (en) Bone-related carboxypeptidase-like protein and process for its production
DK0821969T3 (da) Medicinsk sammensætning omfattende TCF-II
GR3006236T3 (el)
Selye et al. Role of local trauma in production of cutaneous calcinosis by dihydrotachysterol.
AU1200488A (en) Protein c inhibitor (pci) as pharmaceutical and in vitro diagnostic aid, a process for the preparation of a pharmaceutical or diagnostic aid of this type, and an agent containing pci
GB2198351B (en) Improvements in or relating to the use of epidermal growth factor for enhancing the uptake of iron in vivo.
RU1804797C (ru) Способ эндоссальной имплантации
RU2210352C1 (ru) Композиция для лечения воспалительных заболеваний пародонта на основе клеточных культур
Africa An Act (No. 65 of 1983) to provide for the donation or the making available of human bodies and tissue for the purposes of medical or dental training, research or therapy or the advancement of medicine or dentistry in general; for the post-mortem examination of certain human bodies; for the removal of tissue, blood and gametes from the bodies of living persons and the use thereof for medical or dental purposes; for the control of the artificial insemination of persons; and for the regulation of the import and export of human tissue, blood and gametes; and to provide for matters connected therewith. Date of commencement: 12 July 1985 (the Human Tissue Act, 1983)
UA28342A (uk) Спосіб одержання біологічно активної речовини для лікування серцевих захворювань
TH41485A (th) วิธีสำหรับรักษาภาวะการแข็งตัวของเลือดเกินหรือภาวะการพร่องโปรตีนชีที่ได้รับภายหลัง
San Roman et al. Polymer Composite Biomaterials for Surgical Applications: Composites for Orthopaedic Surgery and Bone Reconstruction